About Us | Contact Us |        
LOGIN OR REGISTER
Course Library

Therapeutic Options for Achieving Realistic Management Goals with Your IBS Patients

Gastroenterology
Curriculum:
Achieving Goals with Your IBS Patients
Credits:
1 ANCC Contact Hours 1 AMA PRA Category 1 Credit(s) ™
Launch Date:
February 23, 2016
Expiration Date:
The accreditation for this activity has expired.

Primary Audience:

Primary care physicians; nurse practitioners; and physician assistants

Relevant Terms:

Irritable bowel syndrome

H. Christian Weber, MD

H. Christian Weber, MD
Associate Chief and Clinical Director
Gastroenterology and Hepatology
VA Boston Healthcare System
Assistant Professor of Medicine
Assistant Professor of Pathology and Laboratory Medicine
Boston University School of Medicine
Boston, MA

Dr. Weber joined the faculty of Boston University School of Medicine as Assistant Professor of Medicine in the Section of Gastroenterology in 1997. Dr. Weber is a native of Germany and graduated from Hamburg University Medical School. He completed his training in internal medicine at the University of Mainz, Germany, and at the MetroWest Medical Center in Framingham, MA, and his fellowship in gastroenterology at Georgetown University Medical Center and the National Institutes of Health. He is board-certified in gastroenterology.
 
Dr. Weber's research focuses on the biology and clinical aspects of gastrointestinal hormones. His clinical interests include obesity, gastric acid-related disorders, such as peptic ulcer disease and gastro-esophageal reflux disease (GERD), functional bowel disorders, such as irritable bowel syndrome (IBS), and genetic disorders of the gut. He is a nationally recognized authority in the field of gastrointestinal neuroendocrine tumors (NET), including Zollinger-Ellison syndrome, and has authored or co-authored numerous peer-reviewed original publications, book chapters, reviews and abstracts. Dr. Weber is a member of several professional societies including the American Gastroenterological Association (AGA) and American College of Gastroenterology (ACG) and is also member of editorial boards of several professional journals.

Albena D. Halpert, MD

Albena D. Halpert, MD
Assistant Professor of Medicine
Division of Gastroenterology and Hepatology
Boston University School of Medicine
Gastroenterologist
Pentucket Medical Associates
Haverhill, MA

Dr. Halpert is a gastroenterologist at Pentucket Medical Associates in Haverhill, MA and Assistant Professor in the Section of Gastroenterology at the Boston University School of Medicine in Boston, MA.
 
Dr. Halpert received her Doctor of Medicine degree from Charles University School of Medicine in Prague, Czech Republic. She completed gastroenterology fellowships at St. Louis University in St. Louis, MO and at the Center for Functional Gastrointestinal Disorders at the University of North Carolina at Chapel Hill.
 
Dr. Halpert’s clinical and research interests include the management of functional gastrointestinal and motility disorders such as irritable bowel syndrome, dyspepsia, constipation, and fecal incontinence. Other areas of interest include antidepressant treatment in IBS, patient education and patient – physician relationship.
 
She is a member of the American Gastroenterological Association, the American College of Gastroenterology, and the International Foundation for Functional GI Disorders.
1. Identify symptom criteria for the diagnosis of IBS through history and physical examination
2. Describe screening tools for the diagnosis of IBS and recognize indications for referral to specialist care
3. Articulate the range of treatment options for patients with IBS
4. Interpret consensus guidelines for treatment of IBS
5. Summarize evidence-based guidelines for effective monitoring of patients with IBS
6. Describe the importance of strong clinician-patient communication when establishing realistic long term IBS management goals

DISCLOSURE POLICY STATEMENT
Boston University School of Medicine asks all individuals involved in the development and presentation of Continuing Medical Education (CME) activities to disclose all relationships with commercial interests. This information is disclosed to CME activity participants. Boston University School of Medicine has procedures to resolve any apparent conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed. 
 
Faculty Disclosures
H. Christian Weber, MD discloses he is a consultant for Actavis, Guidepoint Global, Astra Zeneca and Gerson Lehrman Group.
 
Albena D. Halpert, MD has nothing to disclose in regards to commercial support.
 
Off-Label Discussions
The faculty members do not plan on discussing any unlabeled/investigational uses of a commercial product.
 
Planning Committee Disclosures
Rachel Bereiweriso, MSN, AGNP, a nurse practitioner at the VA Boston Healthcare System does not have anything to disclose in regards to commercial support.
 
Michael Burk, Senior Program Manager, Boston University School of Medicine’s Continuing Medical Education Department, has nothing to disclose in regards to commercial support.
 
Patti-Ann Collins, DNP, Boston University’s Continuing Medical Education department’s Lead Nurse Planner, has nothing to disclose with regards to commercial support.
 
Claire Grimble, Program Manager for Boston University’s Continuing Medical Education department, is a minor stockholder of Amgen.
 
Corbett Shelton, MD, Boston University’s Continuing Medical Education department’s independent CME content reviewer, has nothing to disclose with regards to commercial support.
 
DISCLOSURE ATTESTATION
Boston University School of Medicine asks all individuals involved in the development and presentation of Continuing Medical Education (CME) activities to disclose all relationships with commercial interests. This information is disclosed to CME activity participants. Boston University School of Medicine has procedures to resolve apparent conflicts of interest. In addition, faculty members are asked to disclose when any discussion of unapproved use of pharmaceuticals and devices occurs.
 
DISCLAIMER
THESE MATERIALS AND ALL OTHER MATERIALS PROVIDED IN CONJUNCTION WITH CONTINUING MEDICAL EDUCATION ACTIVITIES ARE INTENDED SOLELY FOR PURPOSES OF SUPPLEMENTING CONTINUING MEDICAL EDUCATION PROGRAMS FOR QUALIFIED HEALTH CARE PROFESSIONALS. ANYONE USING THE MATERIALS ASSUMES FULL RESPONSIBILITY AND ALL RISK FOR THEIR APPROPRIATE USE. TRUSTEES OF BOSTON UNIVERSITY MAKES NO WARRANTIES OR REPRESENTATIONS WHATSOEVER REGARDING THE ACCURACY, COMPLETENESS, CURRENTNESS, NONINFRINGEMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OF THE MATERIALS. IN NO EVENT WILL TRUSTEES OF BOSTON UNIVERSITY BE LIABLE TO ANYONE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE MATERIALS. IN NO EVENT SHOULD THE INFORMATION IN THE MATERIALS BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE.
 
Non-Endorsement of Products
Continuing Nursing Education Provider Unit, Boston University School of Medicine’s provider status refers only to continuing nursing education activities and does not imply that there is real or implied endorsement by Continuing Nursing Education Provider Unit, Boston University School of Medicine or ANCC of any product, service, or company referred to in this activity nor of any company subsidizing costs related to the activity.
 
ACCREDITATION STATEMENTS
Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Boston University School of Medicine designates this enduring educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education Provider Unit, Boston University School of Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

CNE Contact Hours: 1.0 all of which are eligible for pharmacology credit. 
 
 
HOW TO RECEIVE CREDIT
By reviewing the course content and successfully completing the post-test and evaluation, physicians are entitled to receive 1.0 AMA PRA category 1 credits™, and nurses are entitled to receive 1.00 CNE contact hours, all of which is pharmacology credit worthy. Statement of credit will be available to print from your user history page.
 
  • Read the learning objectives and faculty disclosures.
  • Participate in the activity.
  • Complete the post-test and activity evaluation.
  • Physicians and nurses who successfully complete the post-test and evaluation will resepectively receive CME, CNE or ACPE credit. You must score with a 70% or higher on the post-test to receive credit for this activity.
  • All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.
 
Release Date: February 23, 2016
Expiration Date: February 23, 2017
Date of Most Recent Review: February 19, 2016
Program Code: E.IBS15
 
For questions about CME, please contact cme@bu.edu or www.bu.edu/cme.
To view Boston University’s Privacy Policy, please see http://www.bumc.bu.edu/cme/policies/.
 
COMMERCIAL SUPPORT
This enduring continuing medical education activity is supprted by educational grants from Takeda Pharmaceuticals U.S.A., Inc., Sucampo, Forest Research Institute, Inc. and Prometheus Laboratories Inc.
 
 
COURSE VIEWING REQUIREMENTS
Supported Browsers:
Internet Explorer 9.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above		 Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
 

Schedule an event with a Standardized Patient
×